Clinical significance of hyperbilirubinemia among HIV-1-infected patients treated with atazanavir/ritonavir through 96 weeks in the CASTLE study.
暂无分享,去创建一个
G. Moyle | D. Butcher | Wenhua Hu | J. Uy | D. McGrath | A. Farajallah | Cheryl Mcdonald | V. Wirtz | S. Juethner